Kura Oncology Announces Launch Of Caspian Therapeutics With $50M Financing Led By BVF Partners, With Eli Lilly Participating, To Advance Menin Inhibitor KO-7246 In Diabetes; Retains About Half Ownership

뉴스 본문을 불러오고 있어요.

Kura Oncology Announces Launch Of Caspian Therapeutics With $50M Financing Led By BVF Partners, With Eli Lilly Participating, To Advance Menin Inhibitor KO-7246 In Diabetes; Retains About Half Ownership | 웨이프 WAPE

Kura Oncology Announces Launch Of Caspian Therapeutics With $50M Financing Led By BVF Partners, With Eli Lilly Participating, To Advance Menin Inhibitor KO-7246 In Diabetes; Retains About Half Ownership

기사 요약

관련 종목

댓글 —